Articles about Corbevax

26 Apr 2022
IndiaIn a significant move, the Drugs Controller General of India (DCGI) on Tuesday cleared two COVID-19 vaccines for use in children aged between five and 12 years.

16 Mar 2022
IndiaIndia on Wednesday started vaccination of children aged 12 to 14 years as it expands its COVID-19 vaccination coverage.

21 Feb 2022
IndiaThe Drugs Controller General of India (DCGI) has granted an emergency use authorization (EUA) to Corbevax—a COVID-19 vaccine developed by Hyderabad-based Biological E—for use in children aged between 12 and 18 years.

06 Nov 2021
IndiaHyderabad-based pharmaceutical company Biological E's COVID-19 vaccine Corbevex's samples were cleared by the Central Drugs Laboratory in Kasauli on Tuesday.

02 Sep 2021
IndiaThe Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its "Made in India" COVID-19 vaccine, Corbevax, on children aged between 5 and 18 years with certain conditions, sources said.